Drug Interaction: Amiodarone-Digoxin Interaction Causing Digoxin Toxicity
This patient is experiencing digoxin toxicity caused by a drug-drug interaction between amiodarone and digoxin. The profound anorexia, nausea, and generalized weakness appearing two weeks after amiodarone initiation are classic gastrointestinal manifestations of elevated digoxin levels.
Mechanism of Interaction
Amiodarone predictably doubles digoxin levels when coadministered 1. This occurs through two mechanisms:
- Inhibition of digoxin secretion from renal tubules
- Inhibition of the P-glycoprotein membrane transporter system
The timing is critical: this patient presented two weeks after amiodarone initiation, which aligns with the expected timeframe for digoxin accumulation to reach toxic levels.
Clinical Presentation Matches Digoxin Toxicity
The FDA label for digoxin explicitly states that digoxin may cause anorexia, nausea, vomiting, and diarrhea 2. These gastrointestinal symptoms are among the most common manifestations of digoxin toxicity, accounting for approximately one-fourth of all adverse reactions. The triad of:
- Profound anorexia
- Nausea
- Generalized weakness
is pathognomonic for digoxin toxicity, particularly in the context of recent amiodarone initiation.
Why This Interaction Was Preventable
Guidelines explicitly recommend reducing digoxin dosage by 50% when amiodarone is started 1. The monitoring checklist for amiodarone therapy specifically includes checking digoxin levels at baseline and during loading phases. This critical dose adjustment was apparently not performed when amiodarone was initiated in the emergency department.
Ruling Out Alternative Diagnoses
The other options are far less likely:
- Gastrointestinal bleeding: Would present with melena, hematemesis, or hemodynamic instability—none mentioned
- Occult carcinoma: Would not present acutely two weeks after medication change
- Pancreatitis: Would present with severe epigastric pain radiating to the back
- Mesenteric ischemia: Would present with severe abdominal pain out of proportion to examination, often with bloody diarrhea
- Erosive gastritis: Could cause nausea but would not explain the generalized weakness or the temporal relationship to amiodarone
Immediate Management
Check a digoxin level immediately 1. The guidelines recommend checking digoxin levels whenever digoxin toxicity is suspected. Additional workup should include:
- Serum potassium (hypokalemia exacerbates digoxin toxicity, and this patient is on furosemide)
- ECG to assess for cardiac manifestations of toxicity
- Renal function (digoxin is renally cleared)
Hold digoxin immediately and do not restart until levels are therapeutic. When restarting, the dose should be reduced by 50% given concurrent amiodarone therapy 1.
Common Pitfall
The critical error here was failing to anticipate and prevent this predictable drug interaction. When amiodarone is added to a patient already taking digoxin, the digoxin dose must be empirically reduced by half before toxicity develops. This is not optional—it is a mandatory dose adjustment based on the known pharmacokinetic interaction. Waiting to check levels after symptoms develop represents a failure of preventive medication management.